It is intended to provide a composition effective for the production of equol in the blood which is to be used for a subject being unable to produce equol by metabolizing daidzein in vivo. Namely, a composition or the like for promoting equol production in the blood of a subject being unable to produce equol, which is characterized by comprising a daidzein type isoflavone and non-fat solid milk components, is provided.